Meissner Paul, Cottler Linda B, Eder Milton Mickey, Michener J Lloyd
Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA.
Clinical and Translational Science Institute, University of Florida, Gainesville, FL, USA.
J Clin Transl Sci. 2020 Jan 20;4(3):216-218. doi: 10.1017/cts.2020.8.
Stakeholder engagement is acknowledged as central to dissemination and implementation (D&I) of research that generates and answers new clinical and health service research questions. There is both benefit and risk in conducting stakeholder engagement. Done wrong, it can damage trust and adversely impact study results, outcomes, and reputations. Done correctly with sensitivity, inclusion, and respect, it can significantly facilitate improvements in research prioritization, communication, design, recruitment strategies, and ultimately provide results useful to improve population and individual health. There is a recognized science of stakeholder engagement, but a general lack of knowledge that matches its strategies and approaches to particular populations of interest based on history and characteristics. This article reviews stakeholder engagement, provides several examples of its application across the range of translational research, and recommends that Clinical Translational Science Awards, with their unique geographical, systems, and historical characteristics, actively participate in deepening our understanding of stakeholder engagement science and methods within implementation and dissemination research. These recommendations include (a) development of an inventory of successful stakeholder engagement strategies; (b) coordination and intentionally testing a variety of stakeholder engagement strategies; (c) tool kit development; and (d) identification of fundamental motivators and logic models for stakeholder engagement to help align stakeholders and researchers.
利益相关者参与被认为是开展能够提出并回答新的临床和卫生服务研究问题的研究的传播与实施(D&I)的核心。进行利益相关者参与既有好处也有风险。如果做得不当,可能会损害信任并对研究结果、成果和声誉产生不利影响。如果以敏感、包容和尊重的态度正确开展,它可以显著促进研究优先级、沟通、设计、招募策略的改进,并最终提供有助于改善人群和个人健康的结果。利益相关者参与有一门公认的科学,但普遍缺乏根据历史和特征将其策略和方法与特定感兴趣人群相匹配的知识。本文回顾了利益相关者参与,提供了其在一系列转化研究中的应用示例,并建议临床转化科学奖凭借其独特的地理、系统和历史特征,积极参与深化我们对实施和传播研究中利益相关者参与科学和方法的理解。这些建议包括:(a)编制成功的利益相关者参与策略清单;(b)协调并有意测试各种利益相关者参与策略;(c)开发工具包;(d)确定利益相关者参与的基本动机和逻辑模型,以帮助使利益相关者和研究人员保持一致。